Csl Behring Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Csl Behring Gmbh

Patent Number:
Title:
Method For Preparing Human Plasma Proteins
Opposition Date:
May 27, 2020
Patent Number:
Title:
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency
Opposition Date:
Mar 28, 2018
Patent Number:
Title:
Oligopeptide-Free Cell Culture Media
Applicant:
Opposition Date:
Jan 18, 2018

Latest patents of Csl Behring Gmbh opposed by its competitors

Patent:
Grant Date:
Mar 17, 2021
Title:
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity
Oppositions:
2
Patent:
Grant Date:
Mar 13, 2019
Title:
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor
Oppositions:
1

Want to track Csl Behring Gmbh?

Feel free to send us a message here and we will get back to you